Subgroup analyses of triple therapy with tamsulosin, dutasteride, and imidafenacin for benign prostatic hyperplasia patients with overactive bladder symptoms refractory to tamsulosin (24-week randomized comparative study: DIrecT Study)

Research Type

Clinical

Abstract Category

Male Lower Urinary Tract Symptoms (LUTS) / Voiding Dysfunction

Links
	Abstract 90
	Open Discussion ePosters Scientific Open Discussion Session 7
	Wednesday 14th September 2016
	12:10 - 12:15 (ePoster Station 3)
	ePoster Area
	Benign Prostatic Hyperplasia (BPH) Clinical Trial Male Overactive Bladder Pharmacology
	1. Dokkyo Medical University, Continence Center, 2. Saitama Medical University Hospital, 3. Kyushu Central Hospital, 4. Medical Information Center, Kyushu University Hospital
Presenter
T Tomonori Yamanishi Dokkyo Medical University, Continence Center
Abstract PDF Edit Abstract Abstract Centre